Research progress of both Human leukocyte antigen typing detections and the correlation between Human leukocyte antigen and ocular diseases

doi:10.3877/cma.j.issn.2095-2007.2018.04.006

Abstract

Abstract:

Human leukocyte antigen (HLA), also known as human major histocompatibility complex. Its classification method has gone through the development of serological typing, cell classification and DNA typing. At present, the DNA typing method is the main HLA typing method, and it has gradually replaced the trend of the other two types of typing detection methods. In addition, many scholars at home and abroad have found that HLA is associated with a variety of diseases. Among them, reports on the correlation between eye diseases and HLA are emerging one after another, especially in the study of uveitis. Therefore, this article intends to review the correlation between HLA typing and ocular diseases.

Key words: Human leukocyte antigen, Uveitis, Behcet's disease, Vogt-Koyanagi-Harada syndrome

Ming Liu, Yinzhang He, Yong Tao. Research progress of both Human leukocyte antigen typing detections and the correlation between Human leukocyte antigen and ocular diseases[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2018, 08(04): 175-180.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2018.04.006

https://zhykyxzz.cma-cmc.com.cn/EN/Y2018/V08/I04/175

References 68

[1]	Dausset J, Brecy H. Identical nature of the leucocyte antigens detectable in monozygotic twins by means of immune iso－leuco－agglutinins[J]. Nature, 1957，180(4599):1430.
[2]	Russell AS, Lentle BC, Schlaut J. Radiologic and scintiscan findings in HLA－B27 negative patients with ankylosing spondylitis[J]. Journal of Rheumatology, 1976，3(3):321-323.
[3]	Tang H, Dalton CF, Srisawat U, et al. Methylation at a transcription factor－binding site on the 5－HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia[J]. International Journal of Neuropsychopharmacology, 2014，17(4):645-649.
[4]	田丁. 人类白细胞抗原的研究进展[J]. 中国免疫学杂志，2009，25(12):1145-1150.
[5]	Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing spondylitis and HL－A 27[J]．Lancet，1973，301(7809):904-907.
[6]	Terasaki PI, Mandell M, Water JVD, et al. Human Blood Lymphoctry Cytotoxicity Reactions With Allogrnic Antisera[J]. Annals of the New York Academy of Sciences, 1964，120(1):322-334.
[7]	张金标，孙黎飞. HLA分子及其与免疫性疾病相关性的研究进展[J]. 实用医药杂志，2013，30(6):558-560.
[8]	宋芳吉，李惠刚. HLA分型方法及其临床意义[J]. 生理科学，1988，8(4):204-215.
[9]	Noreen HJ, Yu N, Setterholm M, et al. Validation of DNA－based HLA－A and HLA－B testing of volunteers for a bone marrow registry through parallel testing with serology[J]. Tissue Antigens, 2001，57(3):221-229.
[10]	谭建明，唐孝达，丁言德. 标准血清学法、单克隆抗体法和DNA法行HLA－A抗原分型的比较[J]. 中华血液学杂志，1998，20(8):395-395.
[11]	周华友，张印则，陈强，等. HLA－A、B血清学分型误定规律分析[J]. 现代医药卫生，2005，21(20):2730-2732.
[12]	周华友，于艳涛，陈强，等. HLA－A、B、DR血清学分型与基因分型的比较研究[J]. 中国输血杂志，2009，22(11):903-905.
[13]	Hurley CK, Maiers M, Ng J, et al. Large－scale DNA－based typing of HLA－A and HLA－B at low resolution is highly accurate specific and reliable[J]. HLA，2000，55(4):352-358.
[14]	Liang B, Zhu L, Liang Z, et al. A Simplified PCR－SSP Method for HLA－A2 Subtype in a Population of Wuhan, China[J]. Chinese Journal of Immunology, 2006，3(6):453-458.
[15]	谭建明，唐孝达，顾文涛，等. 用顺序特异引物聚合酶链反应技术对HLA－B基因分型[J]. 中华微生物学和免疫学杂志，1999，19(4):288-292.
[16]	纪欣，王珏，欧国进，等. Luminex 3D平台在骨髓库供者HLA分型中的应用探讨[J]. 中国输血杂志，2015，28(10):1193-1196.
[17]	Yan YW, Csako G. Rapid and/or high－throughput genotyping for human red blood cell, platelet and leukocyte antigens, and forensic applications[J]. Clinica Chimica Acta, 2006，363(1):165-176.
[18]	Sanger F, Nicklen S, Coulson AR. DNA Sequencing with Chain－Terminating Inhibitors[J]. Proceedings of the National Academy, 1977，74(12):5463-5467.
[19]	Madbouly A, Gragert L, Freeman J, et al. Validation of statistical imputation of allele－level multilocus phased genotypes from ambiguous HLA assignments[J]. Tissue Antigens, 2014，84(3):285-292.
[20]	Lind C, Ferriola D, Mackiewicz K, et al. Next－generation sequencing: the solution for high－resolution, unambiguous human leukocyte antigen typing[J]. Human Immunology, 2010，71(10):1033-1042.
[21]	De Santis D, Dinauer D, Duke J, et al. 16th IHIW : Review of HLA typing by NGS[J]. International Journal of Immunogenetics, 2013，40(1):72-76.
[22]	Zhou M, Gao D, Chai X, et al. Application of high－throughput, high－resolution and cost－effective next generation sequencing－based large－scale HLA typing in donor registry[J]. Tissue Antigens, 2015，85(1):20-28.
[23]	邹义洲，郭靖. NGS在HLA基因分型中的应用[J]. 中国输血杂志，2015，28(10):1211-1213.
[24]	康轶青，刘铮，张丽，等. 流式磁珠PCR－SSOP方法HLA基因分型可疑结果的确认分析[J]. 中国输血杂志，2016，29(7):756-758.
[25]	Dunn PP. Human leucocyte antigen typing: techniques and technology, a critical appraisal[J]. International Journal of Immunogenetics, 2011，38(6):463-473.
[26]	Chang CJ, Osoegawa K, Milius RP, et al. Collection and storage of HLA NGS genotyping data for the 17th International HLA and Immunogenetics Workshop[J]. Human Immunology, 2017，79(2):77-86.
[27]	邹文军，武志峰，项晓丽，等. 人类白细胞抗原－B27阳性急性前葡萄膜炎患者外周血中Th细胞亚群的表达及意义[J]. 中华实验眼科杂志，2012，30(12):1118-1121.
[28]	王大选，陈鹏飞，顾云峰，等. 急性前葡萄膜炎HLA－B27检测及其临床意义[J]. 现代实用医学，2015，27(4):506-508.
[29]	Suhler EB, Martin TM, Rosenbaum JT. HLA－B27 associated uveitis: overview and current perspectives[J]. Current Opinion in Ophthalmology, 2003，14(6):378-383.
[30]	Kopplin LJ, Mount G, Suhler EB. Review for Disease of the Year: Epidemiology of HLA－B27 Associated Ocular Disorders[J]. Ocular Immunology & Inflammation, 2016，24(4):470-475.
[31]	Saari R, Lahti R, Saari KM, et al. Frequency of Rheumatic Diseases in Patients with Acute Anterior Uveitis[J]. Acta Rheumatologica Scandinavica, 2009，11(2):121-123.
[32]	Tay Kearney ML, Schwam BC, Dunn JP, et al. Clinical features and associated systemic diseases of HLA－B27 uveitis[J]. Am J Ophthalmol, 1996，121(1):47-56.
[33]	Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA－B27 uveitis: a study of 175 cases[J]. Ophthalmology, 2004，111(4):802-809.
[34]	Canouï－Poitrine F, Lekpa FK, Farrenq V, et al. Prevalence and factors associated with uveitis in spondylarthritis patients in France: Results from an observational survey[J]. Arthritis Care Res, 2012，64(6):919-924.
[35]	Fernndezmeln J, Muñozfernndez S, Hidalgo V, et al. Uveitis as the initial clinical manifestation in patients with spondyloarthropathies[J]. Journal of Rheumatology, 2004，31(3):524-527.
[36]	刘薇，李嘉，吴振彪. 葡萄膜炎患者检查人类白细胞抗原B27的重要性[J]. 国际检验医学杂志，2016，37(5):642-643.
[37]	Remmers EF, Cosan F, Kirino Y, et al. Genome－wide association study identifies variants in the MHC class Ⅰ， IL10, and IL23R－IL12RB2 regions associated with Behçet's disease[J]. Nature Genetics, 2010，42(8):698-702.
[38]	Behcet H. Uber rezidivierende, aphthose, durch ein Virus verursachte Gaschwure am Mund, am Auge und an den Genitalien[J]. Dermatol Wochenschrift, 1937，36(3):1152-1157.
[39]	Miyanaga M, Kawaguchi T, Miyata K, et al. Indocyanine green angiography findings in initial acute pretreatment Vogt－Koyanagi－Harada disease in Japanese patients[J]. Japanese Journal of Ophthalmology, 2010，54(5):377-382.
[40]	陈茜茜，李军霞，扶晓兰，等. 白塞病遗传学研究进展[J]. 中华风湿病学杂志，2017，21(1):63-66.
[41]	Horie Y, Meguro A, Ohta T, et al. HLA－B51 Carriers are Susceptible to Ocular Symptoms of Behcet Disease and the Association between the Two Becomes Stronger Towards the East Along the Silk Road: A Literature Survey[J]. Ocular Immunology & Inflammation, 2016，25(1):37-40.
[42]	汪运山，申红，刘洋，等. 白塞病患者HLA－B51抗原的变化及意义[J]. 山东医药，2002，42(15):16-17.
[43]	汪运山，李晓兵，潘光锦，等. HLA－B*5101与白塞病的相关性研究[J]. 中国麻风皮肤病杂志，2002，18(4):345-347.
[44]	李晓建，陈明华，郑志忠. HLA－B51与白塞病相关性研究[J]. 中华皮肤科杂志，2009，42(1):22-24.
[45]	Kaya TI, Aysin Kokturk MD, Ayse Polat MD, et al. A case of cutaneous lymphangiectasis secondary to breast cancer treatment[J]. International Journal of Dermatology, 2001，40(12):760-761.
[46]	Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behçet's disease: A comprehensive review[J]. Journal of Autoimmunity, 2015, 64(8):137-148.
[47]	Menthon MD, Lavalley MP, Maldini C, et al. HLA－B51/B5 and the Risk of Behçet's Disease: A Systematic Review and Meta－Analysis of Case－Control Genetic Association Studies[J]. Arthritis Care & Research, 2009，61(10):1287-1296.
[48]	Lee YH, Song GG. Associations between major histocompatibility complex class Ⅰ chain－related gene A polymorphisms and susceptibility to Behcet's disease[J]. Zeitschrift Für Rheumatologie, 2015，74(8):714-721.
[49]	Wei F, Zhang Y, Li W. A meta－analysis of the association between Behcet's disease and MICA－A6[J]. Biomedical Reports, 2016，4(6):741-745.
[50]	Mizuki N, Meguro A, Tohnai I, et al. Association of Major Histocompatibility Complex Class I Chain－Related Gene A and HLA－B Alleles with Behcet's Disease in Turkey[J]. Japanese Journal of Ophthalmology, 2007，51(6):431-436.
[51]	刘勤. VKH综合征与HLA－DR，－DQ基因相关性研究及临床分析[D]．北京：中国协和医科大学，1998.
[52]	于强，曾韶波. Vogt－Koyanagi－Harada综合征与HLA抗原[J]. 眼底病，1989，5(4):205-207.
[53]	刘勤，张美芬，邱长春，等. Vogt－Koyanagi－Harada综合征与人类白细胞抗原－DQA1和－DQB1基因相关性研究[J]. 中华眼科杂志，1999，35(3):210-215.
[54]	Hou S, Du L, Lei B, et al. Genome－wide association analysis of Vogt－Koyanagi－Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3[J]. Nature Genetics, 2014，46(9):1007-1011.
[55]	杨培增，王红，周红颜，等. Vogt－Koyanagi－Harada综合征的临床表现及诊断[J]. 中华眼科杂志，2002，38(12):736-739.
[56]	Islam SM, Numaga J, Matsuki K, et al. Influence of HLA－DRB1 gene variation on the clinical course of Vogt－Koyanagi－Harada disease[J]. Invest Ophthalmol Vis Sci, 1994，35(2):752-756.
[57]	Shindo Y, Inoko H, Nakamura S, et al. Clinical and Immunogenetic Investigation of a Laotian Patient with Vogt－Koyanagi－Harada's Disease[J]. Ophthalmologica, 1996，210(2):112-114.
[58]	Shindo Y, Ohno S, Nakamura S, et al. A significant association of HLA－DPB10501 with Vogt－Koyanagi－Harada's disease results from a linkage disequilibrium with the primarily associated allele, DRB10405[J]. Tissue Antigens, 1996，47(4):344-345.
[59]	Goldberg AC, Yamamoto JH, Chiarella JM, et al. HLA－DRB1*0405 is the predominant allele in Brazilian patients with Vogt－Koyanagi－Harada disease[J]．Hum Immunol, 1998，59(3):183-188.
[60]	Islam SM, Numaga J, Fujino Y, et al. HLA class Ⅱ genes in Vogt－Koyanagi－Harada disease[J]. Invest Ophthalmol Vis Sci, 1994，35(11):3890-3896.
[61]	张美芬，邱长春，胡天圣. Vogt－Koyanagi－Harada综合征与HLA－DRB基因的相关性[J]. 中国医学科学院学报，2000，22(1):36-40.
[62]	肖天林，蒋幼芹，游学科. 人类白细胞抗原－DR4基因亚型与Vogt－Koyanagi－Harada综合征相关性研究[J]. 中华眼科杂志，1997，35(4):268-271.
[63]	闵寒毅，刘英，牛妮芳，等. 我国汉族Vogt－Koyanagi－Harada综合征患者人类白细胞抗原DQB1基因多态性研究[J]. 中华眼底病杂志，2010，26(5):418-422.
[64]	杨培增，周庆芸. 我国葡萄膜炎的基础研究和诊疗现状[J]. 西南医科大学学报，2016，39(3):194-197.
[65]	Shi Y, Jia Y, Hou S, et al. Association of a TNIP1 polymorphism with Vogt－Koyanagi－Harada syndrome but not with ocular Behcet's disease in Han Chinese[J]. Plos One, 2014，9(5):e95573.
[66]	Liu B, Deng T, Zhu L, et al. Association of human leukocyte antigen (HLA)－DQ and HLA－DQA1/DQB1 alleles with Vogt－Koyanagi－Harada disease: A systematic review and meta－analysis[J]. Medicine, 2018，97(7):e9914.
[67]	查优优，魏锐利. 甲状腺相关眼病免疫学发病机制研究进展[J]. 中国实用眼科杂志，2010，28(8):814-816.
[68]	周晓红，罗清礼，夏瑞南. Graves眼病眼眶组织HLA－DR和HSP－70表达的研究[J]. 眼科新进展，2000，20(1):17-20.

Please choose a citation manager

Content to export